FDA Inspection 1261471 — Impladent Ltd.
The FDA completed an inspection of Impladent Ltd. on February 19, 2025 in Jamaica, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 19, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Jamaica, NY (United States)